Methanex Increases its Existing Share Repurchase Program to

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
64
Methanex Increases its Existing Share Repurchase Program to 10% of Public Float

VANCOUVER, British Columbia, July 26, 2017 (GLOBE NEWSWIRE) -- Methanex Corporation (the “Company”) (TSX:MX) (NASDAQ:MEOH) announced today that its Board of Directors has approved an amendment to its existing Normal Course Issuer Bid originally announced on March 6, 2017 (the “Bid”) which increases the number of common shares (“Shares”) that may be purchased under the Bid from 4,492,141 to 6,152,358, representing 10% of the public float at the time of the announcement of the Bid, and the maximum number of common shares that may be purchased under the Bid.

To date, the Company has repurchased 3,755,000 Shares under the Bid at a weighted average purchase price of US$44.66 per share. Commencing August 1, 2017, the remaining shares under the amended Bid may be purchased on the open market through the facilities of the Toronto Stock Exchange (the “TSX”) up to and including March 12, 2018. The Company has received TSX approval of the amended Bid.  No other terms of the Bid have been amended.

John Floren, President and CEO of Methanex commented, “Our announcement of an increase to the existing share repurchase program builds on a long track record of returning excess cash to shareholders.  As we continue to achieve excellent production and sales results, we have the capacity to generate strong cash flows at a range of methanol prices. With a solid liquidity position and strong balance sheet, we have the financial strength and flexibility to meet all of our financial and capital commitments, pursue our near-term growth opportunities in Chile, and deliver on our commitment to return excess cash to shareholders.”

Purchases will be made from time to time at the then current market price of the Shares and all Shares purchased will be cancelled. Subject to certain exceptions for block purchases, daily repurchases under the program will not exceed 75,192 common shares, representing 25 percent of the Company's average daily trading volume on the TSX for the six month period ended on February 28, 2017.  The Company has entered into an automatic securities purchase plan with its broker in connection with purchases to be made under this program.

Methanex is a Vancouver-based, publicly traded company and is the world's largest producer and supplier of methanol to major international markets. Methanex shares are listed for trading on the Toronto Stock Exchange in Canada under the trading symbol "MX" and on the NASDAQ Global Select Market in the United States under the trading symbol "MEOH".

FORWARD-LOOKING INFORMATION WARNING

This press release contains certain forward-looking statements with respect to us and our industry. These statements relate to future events or our future performance. All statements other than statements of historical fact are forward looking statements. Statements that include the words "expect", and "continue" or other comparable terminology and similar statements of a future or forward-looking nature identify forward-looking statements. More particularly and without limitation, any statements regarding the following are forward-looking statements:

  • Methanex’s expected future financial strength and cash generation capability, and
  • Methanex's ability to continue to return excess cash to shareholders.

We believe that we have a reasonable basis for making such forward-looking statements. The forward-looking statements in this document are based on our experience, our perception of trends, current conditions and expected future developments as well as other factors. Certain material factors or assumptions were applied in drawing the conclusions or making the forecasts or projections that are included in these forward-looking statements, including, without limitation, future expectations and assumptions concerning the following:

  • the supply of, demand for, and price of methanol, methanol derivatives, natural gas, coal, oil and oil derivatives,
  • operating rates of our facilities,
  • operating costs including natural gas feedstock and logistics costs, capital costs, tax rates, cash flows, foreign exchange rates and interest rates, and
  • global and regional economic activity (including industrial production levels).

However, forward-looking statements, by their nature, involve risks and uncertainties that could cause actual results to differ materially from those contemplated by the forward-looking statements. The risks and uncertainties primarily include those attendant with producing and marketing methanol and successfully carrying out major capital expenditure projects in various jurisdictions, including without limitation:

  • conditions in the methanol and other industries including fluctuations in the supply, demand for and price of methanol and its derivatives, including demand for methanol for energy uses,
  • the price of natural gas, coal, oil and oil derivatives,
  • our ability to obtain natural gas feedstock on commercially acceptable terms to underpin current operations and future growth opportunities,
  • the ability to successfully carry out corporate initiatives and strategies,
  • actions of competitors, suppliers and financial institutions,
  • world-wide economic conditions, and
  • other risks described in our 2016 Annual Management's Discussion and Analysis and our Second Quarter 2017 Management's Discussion and Analysis.

Having in mind these and other factors, investors and other readers are cautioned not to place undue reliance on forward-looking statements. They are not a substitute for the exercise of one's own due diligence and judgment. The outcomes anticipated in forward-looking statements may not occur and we do not undertake to update forward-looking statements except as required by applicable securities laws.

For further information, contact:

Sandra Daycock
Director, Investor Relations
Tel: 604 661 2600
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Novo's Research Unlocks New Insights into Food Noise

Updated Category News Views 356

Unpacking the Science Behind Food Noise When folks think about losing weight, most picture shedding pounds and fitting into those elusive smaller jeans. But get this—there’s a curveball called ‘food noise’ that’s making waves in obesity treatment. Novo Nordisk’s semaglutide injections are shaking things up, cutting down on those persistent thoughts about food....

Continue Reading
Novo's CagriSema Trial Shows Promising Obesity Results

Updated Category News Views 371

Novo's Latest Weight Loss Gamble Well, look what we have here. Novo Nordisk is shaking up the obesity treatment scene with some bold numbers from their REDEFINE 9 trial. The investigational CagriSema combo of amylin analog and GLP-1 receptor agonist has churned out an eyeball-popping near 21% weight loss. For context, we're staring down the barrel of numbers far meatier...

Continue Reading
HONGQI's EHS4 Launch in Europe: Bridging East and West

Updated Category News Views 150

Revving Up a New Chapter: HONGQI in Venice There's a new player in the European automotive scene, and it's rolling in with more style than a Venetian gondola. HONGQI, a name that's been turning gears in China since '58, is packing its suitcases full of Eastern elegance and landing straight in Venice with the all-electric EHS4. On November 16, the brand is set to unveil...

Continue Reading
CARsgen's CAR-T Breakthrough on China's Insurance List

Updated Category News Views 347

A Game Changer for CAR-T Therapies There's a breeze of optimism blowing from Shanghai these days—a rare sensation in this market of endless skirmishes. CARsgen Therapeutics Holdings Limited, a company entrenched in the development of cutting-edge CAR T-cell therapies, just notched a victory. They've announced that their CAR T-cell therapy product, satricabtagene...

Continue Reading
EFICYENT Ventures to Connect at Singapore FinTech Fest

Updated Category News Views 204

Why the Singapore FinTech Festival Matters The world's hardly a stranger to hype, but the Singapore FinTech Festival carries some real weight. From November 18 to 20, 2026, this gig isn't just industry chatter—it's a high-stakes convergence of policymakers, financial institutions, fintech innovators like EFICYENT, and the money folk looking to mold the future of...

Continue Reading
Retirement Dreams Dashed: 61% Withdraw Early

Updated Category News Views 309

Retirement Caught in the Crosshairs Just when you think the path to retirement might clear up, life slaps down older workers with economic reality. A recent LiveCareer survey underscores this financial mess, revealing that 61% of those 50 and older are raiding their own retirement funds to make ends meet. It's enough to make one's head spin. Inflation: The Unwanted Guest...

Continue Reading
EZaccessMD Data Breach: Class Action Lawsuit Looms

Updated Category News Views 238

Data breaches are the bogeyman no one wants lurking in the shadows, and when it’s your personal info at stake, folks rightfully squirm. This recent fiasco at EZaccessMD is one of those unsettling incidents. The word on the street isn't pretty: sensitive medical data has slipped through the cracks, leaving Edelson Lechtzin LLP, a heavyweight in class action maneuvers, to...

Continue Reading
WeaveGrid Powers EVConnectNC: Charging Incentives Launched

Updated Category News Views 177

Transforming Utilities with EVConnectNC In a fresh move by WeaveGrid, North Carolina's Electric Cooperatives have teamed up to roll out EVConnectNC. This innovative program aims to manage the burgeoning demand for electric vehicle (EV) charging in rural and suburban areas under North Carolina's cooperative umbrella. Think of it as a smart way to handle new loads without...

Continue Reading
Servier's Data on Tovorafenib Shows Promise in pLGG

Updated Category News Views 433

New Light on a Critical Challenge Talk about a fight in the dark. Pediatric low-grade glioma (pLGG) is a menace that families dread, an uphill battle with odds that feel relentless. Enter Servier and its four-year updated data on OJEMDA® (tovorafenib), a beacon of hope for kids battling these tricky brain tumors. Results, presented at the SNO meeting, are fresh off the...

Continue Reading
Lilly's Obesity Breakthroughs: A Step Beyond the Scale

Updated Category News Views 243

Pushing the Boundaries of Obesity Treatment Alright, let's cut through the noise and get to what really matters here. Eli Lilly is taking on obesity treatment like it's Clash of the Titans at this year's ObesityWeek 2026 in Washington, D.C. Forget just dropping pounds—Lilly wants to reshape how we think about obesity entirely. They're not just leaning into the scale,...

Continue Reading

Top 5 Most Recently Viewed Articles

Cryptocurrency Market Analysis: Bitcoin Hits New Low

Updated Category News Views 197

Cryptocurrency Market Update On Friday morning, cryptocurrency enthusiasts awoke to disappointing news: Bitcoin has fallen below $109,000, marking a significant decline for the leading digital asset. This marks the first time Bitcoin has dipped below this level since early September, raising questions about the current state and future of digital currencies. Key...

Continue Reading
Hagar hf. Expands Operations with P/F SMS Acquisition

Updated Category News Views 239

Hagar hf. Expands Its Business Footprint Recently, a significant announcement was made about Hagar hf. enhancing its business strategy through the acquisition of P/F SMS, a prominent supermarket chain in the Faroe Islands. This strategic move was publicized on a notable occasion, indicating the completion of a conditional agreement that allows Hagar hf. to fully acquire...

Continue Reading
Santander Achieves Impressive 12% Net Profit Growth in Q3

Updated Category News Views 238

Santander's Robust Net Profit Growth in Q3 Spain's Santander has announced an impressive 12% increase in net profit for the third quarter of 2023, underscoring the effectiveness of its retail operations. This remarkable performance has positioned the bank as one of the strongest contenders in the euro zone banking sector. Financial Highlights for Q3 In the latest...

Continue Reading
DBM Global Secures $220 Million Credit Facility for Growth

Updated Category News Views 318

DBM Global Inc. Enters Amended Credit Facility Agreement DBM Global Inc. (OTC Markets: DBMG) has recently made headlines by securing an amended and restated credit agreement that amounts to a significant total of $220 million. This financial maneuver comprises an $85 million term loan alongside a $135 million revolving credit facility, which aims to address existing debt...

Continue Reading
Projected Growth of Industrial Safety Market to USD 12.39 Billion

Updated Category News Views 82

Overview of the Industrial Safety Market Growth The Industrial Safety Market is experiencing remarkable growth, expected to expand from USD 6.74 billion in 2023 to a substantial USD 12.39 billion by 2032. This notable surge is attributed to a compound annual growth rate (CAGR) of 7%, reflecting an increased emphasis on safety within various industrial sectors. Key Factors...

Continue Reading